中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
10期
42-43
,共2页
新生儿溶血病%高胆红素血症%外周动静脉同步换血治疗
新生兒溶血病%高膽紅素血癥%外週動靜脈同步換血治療
신생인용혈병%고담홍소혈증%외주동정맥동보환혈치료
Hemolytic disease of the newborn%Hyperbilirubinemia%Peripheral arteriovenous synchronous exchange transfusion
目的：探讨外周动静脉同步换血治疗新生儿溶血病的临床效果。方法选择该院26例新生儿溶血病患儿，所有患儿均实施外周动静脉同步换血治疗。观察换血治疗前和治疗后的血清总胆红素、间接胆红素及直接胆红素水平改变情况。结果所有患儿均换血治疗成功，换血治疗后血清总胆红素（238±42）μmol/L、间接胆红素（215±32）μmol/L及直接胆红素（18±10）μmol/L水平均显效低于治疗前血清总胆红素（517±39）μmol/L、间接胆红素（477±51）μmol/L及直接胆红素（39±11）μmol/L，差异有统计学意义（P<0.05）。结论外周动静脉同步换血治疗新生儿溶血病疗效显著，能够显著改善患儿临床症状，值得借鉴。
目的：探討外週動靜脈同步換血治療新生兒溶血病的臨床效果。方法選擇該院26例新生兒溶血病患兒，所有患兒均實施外週動靜脈同步換血治療。觀察換血治療前和治療後的血清總膽紅素、間接膽紅素及直接膽紅素水平改變情況。結果所有患兒均換血治療成功，換血治療後血清總膽紅素（238±42）μmol/L、間接膽紅素（215±32）μmol/L及直接膽紅素（18±10）μmol/L水平均顯效低于治療前血清總膽紅素（517±39）μmol/L、間接膽紅素（477±51）μmol/L及直接膽紅素（39±11）μmol/L，差異有統計學意義（P<0.05）。結論外週動靜脈同步換血治療新生兒溶血病療效顯著，能夠顯著改善患兒臨床癥狀，值得藉鑒。
목적：탐토외주동정맥동보환혈치료신생인용혈병적림상효과。방법선택해원26례신생인용혈병환인，소유환인균실시외주동정맥동보환혈치료。관찰환혈치료전화치료후적혈청총담홍소、간접담홍소급직접담홍소수평개변정황。결과소유환인균환혈치료성공，환혈치료후혈청총담홍소（238±42）μmol/L、간접담홍소（215±32）μmol/L급직접담홍소（18±10）μmol/L수평균현효저우치료전혈청총담홍소（517±39）μmol/L、간접담홍소（477±51）μmol/L급직접담홍소（39±11）μmol/L，차이유통계학의의（P<0.05）。결론외주동정맥동보환혈치료신생인용혈병료효현저，능구현저개선환인림상증상，치득차감。
Objective To discuss the clinical effect of peripheral arteriovenous synchronous exchange transfusion on neonatal hemolytic disease. Methods 26 cases of neonatal hemolytic disease admitted in our hospital were selected. The peripheral arteriovenous synchronous exchange transfusion was implemented in all children. The change of the level of serum total bilirubin, indirect bilirubin and direct bilirubin before and after the peripheral arteriovenous synchronous exchange transfusion was observed. Results All the cases were successfully treated. After the treatment, the patients' serum total bilirubin was [(238±42)μmol/L], indirect bilirubin was [(215±32)μmol/L], and direct bilirubin was [(18±10)μmol/L], which were markedly lower than those[(517± 39)μmol/L, (477 ±51)μmol/L、(39 ±11)μmol/L] before the treatment, the differences were statistically significant (P<0.05). Conclusion Peripheral arteriovenous synchronous exchange transfusion is quite effective in the treatment of neonatal hemolytic disease, which can significantly improve the clinical symptoms and is worthy of reference.
